(Q86999665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

main subject

acute myeloid leukemia

1 reference

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Masamitsu Yanada

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Shigeki Ohtake

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Shuichi Miyawaki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hisashi Sakamaki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Toru Sakura

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Tomoya Maeda

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Koichi Miyamura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Norio Asou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Iekuni Oh

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Junichi Miyatake

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hiroyuki Kanbayashi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jin Takeuchi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Masatomo Takahashi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Nobuaki Dobashi

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Hitoshi Kiyoi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Yasushi Miyazaki

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Nobuhiko Emi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Ryuzo Ohno

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Tomoki Naoe

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Japan Adult Leukemia Study Group

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

24 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

3326-3333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

Drug therapy for acute myeloid leukemia

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Acute myeloid leukemia and myelodysplastic syndromes in older patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Acute myeloid leukemia in older adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Age and acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan A

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Monosomal karyotype in acute myeloid leukemia: a better indicator of poor prognosis than a complex karyotype

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

AML at older age: age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

High-dose daunorubicin in older patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Long-term outcomes for unselected patients with acute myeloid leukemia categorized according to the World Health Organization classification: a single-center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.28212

7 January 2021

Identifiers

DOI

10.1002/CNCR.28212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23798329%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference